Amyotrophic Lateral Sclerosis Gene Testing Market

Future Market Insights

Amyotrophic Lateral Sclerosis Gene Testing Market

Key Insight

The amyotrophic lateral sclerosis gene testing market is projected to grow from USD 120.0 million in 2025 to USD 284.1 million by 2035, at a CAGR of 9.0%. Targeted ALS Gene Panel will dominate with a 38.0% market share, while neuromuscular/als centers will lead the customer segment with a 34.0% share.

October 30, 2025

Anurag Sharma

250 Pages

Cite this Report

Amyotrophic Lateral Sclerosis Gene Testing Market

https://www.futuremarketinsights.com/reports/amyotrophic-lateral-sclerosis-gene-testing-market

License

Buy Now

Summary ToC Companies

Key Players

Ambry Genetics
Baylor Genetics
Centogene
Fulgent Genetics Inc
GeneDx
Invitae Corporation
LabCorp
Mayo Clinic Laboratories
NEALS Consortium Labs
Quest Diagnostics

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Amyotrophic Lateral Sclerosis Gene Testing Market

Key Players

Similar Industry Reports